Adenovirus: a blueprint for non-viral gene delivery

被引:21
|
作者
Chailertvanitkul, V. Ann [1 ]
Pouton, Colin W. [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3004, Australia
关键词
NUCLEAR-PORE COMPLEX; INTRACELLULAR TRAFFICKING; PROTEIN IMPORT; IN-VITRO; RECEPTOR; VIRUS; DNA; THERAPY; FIBER; EXPRESSION;
D O I
10.1016/j.copbio.2010.06.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Although adenoviral vectors may not find a direct clinical role in gene therapy, an understanding of the mechanisms of DNA delivery that adenoviruses use is of vital importance to the design of next-generation non-viral gene delivery systems. Adenoviruses overcome a series of biological barriers, including endosomal escape, intracellular trafficking, capsid dissociation, and nuclear import of DNA, to deliver their genome to the host cell nucleus. The understanding of these processes at the molecular level is progressing and is set to inform the design of synthetic gene delivery systems.
引用
收藏
页码:627 / 632
页数:6
相关论文
共 50 条
  • [31] Non-viral Delivery Systems for Breast Cancer Gene Therapy
    Vaseghi, Golnaz
    Rafiee, Laleh
    Javanmard, Shaghayegh Haghjooy
    CURRENT GENE THERAPY, 2017, 17 (02) : 147 - 153
  • [32] DNA Nuclear Targeting Sequences for Non-Viral Gene Delivery
    Ethlinn V. B. van Gaal
    Ronald S. Oosting
    Roel van Eijk
    Marta Bakowska
    Dries Feyen
    Robbert Jan Kok
    Wim E. Hennink
    Daan J. A. Crommelin
    Enrico Mastrobattista
    Pharmaceutical Research, 2011, 28 : 1707 - 1722
  • [33] PEGylated bioreducible poly(amido amine)s for non-viral gene delivery
    Lin, Chao
    Engbersen, Johan F. J.
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2011, 31 (07): : 1330 - 1337
  • [34] Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases
    Jiao, Liping
    Sun, Zhuokai
    Sun, Zhihong
    Liu, Jie
    Deng, Guanjun
    Wang, Xiaozhong
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [35] Polyethylenimine-based non-viral gene delivery systems
    Lungwitz, U
    Breunig, M
    Blunk, T
    Göpferich, A
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (02) : 247 - 266
  • [36] Non-viral polyplexes: Scaffold mediated delivery for gene therapy
    O'Rorke, Suzanne
    Keeney, Michael
    Pandit, Abhay
    PROGRESS IN POLYMER SCIENCE, 2010, 35 (04) : 441 - 458
  • [37] Poloxamine/fibrin hybrid hydrogels for non-viral gene delivery
    Zhang, Jeremy
    Sen, Atanu
    Cho, Eunhee
    Lee, Jeoung Soo
    Webb, Ken
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2017, 11 (01) : 246 - 255
  • [38] Synthetic biodegradable polymeric materials in non-viral gene delivery
    Panchal, Siddhi S.
    Vasava, Dilip V.
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2024, 73 (06) : 478 - 489
  • [39] Overcoming barriers in non-viral gene delivery for neurological applications
    Tasset, Aaron
    Bellamkonda, Arjun
    Wang, Wenliang
    Pyatnitskiy, Ilya
    Ward, Deidra
    Peppas, Nicholas
    Wang, Huiliang
    NANOSCALE, 2022, 14 (10) : 3698 - 3719
  • [40] Sucrose ester based cationic liposomes as effective non-viral gene vectors for gene delivery
    Zhao, Yinan
    Zhu, Jie
    Zhou, Hengjun
    Guo, Xin
    Tian, Tian
    Cui, Shaohui
    Zhen, Yuhong
    Zhang, Shubiao
    Xu, Yuhong
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 145 : 454 - 461